1st Quarter - Report
GOODWIN PROCTER LLP for TEVA PHARMACEUTICALS USA INC
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 23 (Patent Reform Act of 2011) and H.R. 1249 (The American Invents Act). (All provisions for all bills.)
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELAINE BLAIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.